| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PDS.1507 |
| P698 | PubMed publication ID | 17944002 |
| P50 | author | Charles Quesenberry | Q102048181 |
| Natalia Udaltsova | Q114454712 | ||
| P2093 | author name string | James Chan | |
| Laurel A Habel | |||
| Gary D Friedman | |||
| E Dawn Flick | |||
| P2860 | cites work | Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force | Q22241141 |
| Current perspectives on statins | Q33818381 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 27-36 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Pharmacoepidemiology and Drug Safety | Q15759496 |
| P1476 | title | Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361,859 recipients | |
| P478 | volume | 17 |
| Q37680946 | A clinical review of statins and cancer: helpful or harmful? |
| Q59789531 | Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer |
| Q44538922 | Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression? |
| Q50052677 | An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative |
| Q93163237 | Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer |
| Q36877126 | Association between plasma cholesterol and prostate cancer in the PSA era. |
| Q34418735 | Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort |
| Q35069176 | Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database |
| Q34387037 | Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies |
| Q34415704 | Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III. |
| Q24614649 | Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery |
| Q38611423 | Associations between statin use and non-Hodgkin lymphoma (NHL) risk and survival: a meta-analysis |
| Q36584020 | Atorvastatin (Lipitor) attenuates the effects of aspirin on pancreatic cancerogenesis and the chemotherapeutic efficacy of gemcitabine on pancreatic cancer by promoting M2 polarized tumor associated macrophages |
| Q42371605 | BMI and serum lipid parameters predict increasing risk and aggressive prostate cancer in Chinese people |
| Q38147841 | Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates |
| Q35204387 | Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection |
| Q37413636 | Can statins reduce risk of lung cancer, especially among elderly people? A meta-analysis |
| Q28821882 | Cancer risk in older people receiving statin therapy: a meta-analysis of randomized controlled trials |
| Q27026428 | Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer |
| Q44270613 | Common cancer risk and statins: a population-based case-control study in a Chinese population |
| Q36330625 | Continuation with statin therapy and the risk of primary cancer: a population-based study |
| Q81407191 | Current awareness: pharmacoepidemiology and drug safety |
| Q53050654 | Does statin use affect the risk of developing prostate cancer? |
| Q38030598 | Dyslipidemia, statins and prostate cancer |
| Q35148792 | Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials |
| Q34997752 | Effects of statins on the risk of hepatocellular carcinoma |
| Q36584280 | Endometrial Cancer and The Role of Statins |
| Q24604561 | Epidemiologic characteristics and risk factors for renal cell cancer |
| Q34028899 | Exposure to statins and risk of common cancers: a series of nested case-control studies |
| Q37646768 | Ezetimibe/simvastatin |
| Q37818297 | Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer. |
| Q39656423 | Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells |
| Q46798905 | Germline BRCA mutation in male carriers-ripe for precision oncology? |
| Q36461735 | Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability |
| Q38414609 | Hypercholesterolemia Is Associated with a Shorter Time to Castration-Resistant Prostate Cancer in Patients Who Have Undergone Androgen Deprivation Therapy |
| Q26801352 | Impact of statins on risk and survival of ovarian cancer |
| Q43279302 | Incidence of cancer and statin usage--record linkage study |
| Q33645618 | Integrating systems biology sources illuminates drug action |
| Q35988999 | LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies. |
| Q34185642 | Lipophilic statin use and risk of breast cancer subtypes |
| Q37163342 | Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age |
| Q37520501 | Long-term statin use in patients with lung cancer and dyslipidemia reduces the risk of death |
| Q49823811 | Low-dose statin treatment increases prostate cancer aggressiveness. |
| Q33882778 | Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial |
| Q36919251 | Meta-analysis of studies using statins as a reducer for primary liver cancer risk. |
| Q51156222 | Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: a simulation study. |
| Q26741176 | Pleiotropic effects of statins in the diseases of the liver |
| Q53063710 | Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial. |
| Q38802230 | Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients? |
| Q34898182 | Reduced esophageal cancer incidence in statin users, particularly with cyclo-oxygenase inhibition |
| Q54209299 | Risk of gastric cancer development after eradication of Helicobacter pylori. |
| Q37621036 | Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus |
| Q34158413 | Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness. |
| Q34441859 | Screening pharmaceuticals for possible carcinogenic effects: initial positive results for drugs not previously screened. |
| Q36407365 | Serum total and HDL cholesterol and risk of prostate cancer |
| Q41295014 | Statin Use and Serum Lipid Levels Are Associated With Survival Outcomes After Surgery for Renal Cell Carcinoma |
| Q90396804 | Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies |
| Q91884090 | Statin Use and the Risk of Prostate Cancer in Ischemic Heart Disease Patients in Taiwan |
| Q26738631 | Statin Use in Prostate Cancer: An Update |
| Q34003588 | Statin and NSAID use and prostate cancer risk |
| Q34433564 | Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004. |
| Q35282895 | Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database |
| Q35268601 | Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study |
| Q34021312 | Statin use and cancer risk: a comprehensive review |
| Q30497454 | Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial |
| Q35332074 | Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies. |
| Q42180641 | Statin use and endometrial cancer risk: a meta-analysis |
| Q34585472 | Statin use and female reproductive organ cancer risk in a large population-based setting |
| Q35677748 | Statin use and risk for ovarian cancer: a Danish nationwide case-control study. |
| Q37237201 | Statin use and risk of basal cell carcinoma |
| Q34325144 | Statin use and risk of bladder cancer: a meta-analysis |
| Q34288756 | Statin use and risk of breast cancer: a meta-analysis of observational studies |
| Q40454898 | Statin use and risk of endometrial cancer: a nationwide registry-based case-control study. |
| Q87550597 | Statin use and risk of hepatocellular carcinoma in a U.S. population |
| Q26864662 | Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials |
| Q34198230 | Statin use and risk of liver cancer: an update meta-analysis |
| Q35035835 | Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials |
| Q38692861 | Statin use and risk of multiple myeloma: An analysis from the cancer research network. |
| Q34273115 | Statin use and risk of pancreatic cancer: a meta-analysis. |
| Q35365005 | Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study |
| Q35152907 | Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink |
| Q21133952 | Statin use and risk of prostate cancer: a meta-analysis of observational studies |
| Q47319683 | Statin use and the risk of bladder cancer: a population-based case-control study |
| Q92151619 | Statin use and the risk of ovarian and endometrial cancers: a meta-analysis |
| Q44560037 | Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies |
| Q35354232 | Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts |
| Q43493272 | Statin use is associated with a reduced incidence of colorectal adenomatous polyps |
| Q34244183 | Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case-control study |
| Q43960201 | Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study |
| Q39828211 | Statin use is associated with improved prostate cancer survival: is it time for a clinical trial? |
| Q34757109 | Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma |
| Q37538571 | Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis |
| Q88264960 | Statin use linked with a decrease in the conversion from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer |
| Q37119810 | Statins and Breast Cancer: Future Directions in Chemoprevention |
| Q36988768 | Statins and colorectal cancer |
| Q43973857 | Statins and colorectal cancer risk: a longitudinal study |
| Q59150549 | Statins and metformin for chemoprevention of hepatocellular carcinoma |
| Q35264079 | Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins |
| Q26864624 | Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies |
| Q21559688 | Statins and the risk of lung cancer: a meta-analysis |
| Q37206323 | Statins are Associated With a Reduced Risk of Brain Cancer: A Population-Based Case-Control Study |
| Q34324864 | Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett's esophagus: a systematic review and meta-analysis |
| Q34349560 | Statins are associated with reduced risk of gastric cancer: a meta-analysis |
| Q35602162 | Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies |
| Q39425042 | Systematic Review and Meta-analysis: Use of Statins Is Associated with a Reduced Incidence of Oesophageal Adenocarcinoma. |
| Q27024919 | Systematic review: potential preventive effects of statins against oesophageal adenocarcinoma |
| Q57028079 | The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials |
| Q36729573 | The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer |
| Q38549743 | The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer |
| Q34206127 | The association between statin medication and progression after surgery for localized renal cell carcinoma |
| Q34590302 | The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer |
| Q38800777 | The current evidence on statin use and prostate cancer prevention: are we there yet? |
| Q45781693 | The effect of statins on risk and survival of gynecological malignancies |
| Q38168762 | The spectrum of statin therapy in cancer patients: is there a need for further investigation? |
| Q37095209 | Therapeutic potential of statins in thyroid proliferative disease. |
| Q33548538 | Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer |
| Q35815590 | Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus |
Search more.